• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS27
Device Problems Perivalvular Leak (1457); Malposition of Device (2616)
Patient Problems Aortic Insufficiency (1715); Death (1802); Sepsis (2067)
Event Date 08/23/2016
Event Type  Death  
Manufacturer Narrative
Not explanted.
 
Event Description
On (b)(6) 2016, a percival valve size xl was implanted in a patient with an (b)(6) active valve endocarditis (limited to the leaflets without annular involvement).During the same surgery a double cabg was performed.The intra-operative tee did not show presence of valvular leaks.Patient experienced difficulty coming off bypass and an intra-aortic balloon pump was implanted.Two hours after the surgery, tte was performed and a perivalvular leak was detected around the anterior aspect of the percival.The aortic balloon pump was removed and an impala lvad was implanted.On (b)(6) 2016 patient was taken to the catheterization lab, a 25mm balloon catheter was inflated at the subangular level of the percival's inflow ring.Simultaneously a catheter-introduced grasper was attached to the valve's outflow ring.With this maneuver the percival's tilt was corrected and the tee showed good valvular gradient and the paravalvular leak was completely resolved.The patient later succumbed to sepsis.The surgeon feels the patient death was not valve-related.
 
Manufacturer Narrative
The complete manufacturing and material records for the perceval heart valve, model icv1211, s/n (b)(4), were pulled and reviewed by quality control at livanova (b)(4) corp.The results confirmed that this valve satisfied all material, visual, and performance standards required for a perceval heart valve at the time of manufacture and release.Based on the medical judgement provided, the patient died as a result of sepsis and was not related to the valve.No further investigation is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
4125650
MDR Report Key5975469
MDR Text Key55562628
Report Number3004478276-2016-00109
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000443
UDI-Public(01)00896208000443(240)ICV1211(17)190314
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/14/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/14/2019
Device Model NumberPVS27
Device Catalogue NumberICV1211
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/20/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/14/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age55 YR
Patient Weight61
-
-